Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Trial Identifier: D419CC00026
Sponsor: AstraZeneca
NCTID:: NCT05667064
Start Date: May 2023
Primary Completion Date: October 2024
Study Completion Date: October 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aomori, Japan
Japan Chiba, Japan
Japan Ehime, Japan
Japan Fukuoka, Japan
Japan Hokkaido, Japan
Japan Hyogo, Japan
Japan Iwate, Japan
Japan Kagawa, Japan
Japan Kanagawa, Japan
Japan Kyoto, Japan
Japan Nagasaki, Japan
Japan Okayama, Japan
Japan Osaka, Japan
Japan Saitama, Japan
Japan Tokushima, Japan
Japan Tokyo, Japan
Japan Wakayama, Japan